Table 2: Current and past opioid and non-opioid pharmacological therapies for pain in MFS (n = 218). Individuals may report use of more than one treatment.
| Current (%) | Past (%) | ||
|---|---|---|---|
| Opioids | Oxycodone | 15.6 | 26.1 |
| Hydrocodone | 13.3 | 29.4 | |
| Tramadol | 10.6 | 22.0 | |
| Codeine | 7.3 | 19.7 | |
| Morphine | 6.0 | 12.4 | |
| Hydromorphone | 3.2 | 10.1 | |
| Fentanyl patch | 1.8 | 6.9 | |
| Propoxyphene | 0.9 | 7.3 | |
| Non-Opioids | Gabapentin | 9.2 | 15.1 |
| Lidocaine patch | 5.5 | 11.9 | |
| Steroids | 4.6 | 14.7 | |
| Herbal supplements | 4.1 | 11.9 | |
| Cox-2 inhibitors | 2.3 | 10.6 | |
| Topiramate | 1.8 | 8.7 | |
| Clonidine | 0.9 | 3.2 | |
| Antidepressants | 3.2 | 0.9 | |
| Pregabalin | 0.9 | 0 |